| Quote | Spy HITK NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Hi-Tech Pharma Announces Q4 EPS of $0.67, Beats Views
HITK Linked by StreetInsider - March 11, 08:11AM from (www.streetinsider.com) more ...
Hi-Tech Pharmacal Reports Results for the Third Fiscal Quarter Ended January 31, 2010
HITK Linked by BusinessWire - March 11, 08:00AM from (www.businesswire.com) Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the quarter ended January 31, 2010. For the three months more ...
Small Cap # 5: Hi-Tech Pharmacal (HITK)
HITK Linked by BloggingStocks - March 07, 01:00PM from (www.bloggingstocks.com) Hi-Tech Pharmacal (HITK) is scheduled as one of the last companies to post a quarterly report this earnings season. However, more ...
Five Top Small Cap Gems
CGA CACC HITK PCLN FIRE Linked by BloggingStocks - March 06, 09:00AM from (www.bloggingstocks.com) The market's rebound after a rough start to February has proven that this bull market still has some legs. But I must warn more ...
Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 11, 2010
HITK Linked by BusinessWire - March 05, 08:00AM from (www.businesswire.com) Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its third quarter of Fiscal more ...
Hi-Tech Pharmacal Acquires Mag-Ox® line of Magnesium Supplements from Blaine Company, Inc.
HITK Linked by BusinessWire - March 02, 08:00AM from (www.businesswire.com) Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) announced today the signing of a definitive agreement under which Hi-Tech acquired more ...
Hi-Tech Pharmacal's ECR Subsidiary to Co-Promote Unique Kidney Stone Treatment
HITK Linked by BusinessWire - February 16, 08:00AM from (www.businesswire.com) Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced today that its branded marketing subsidiary, ECR Pharmaceuticals will more ...
Hi-Tech Pharmacal Reports Strong Q2 Earnings
HITK Linked by StreetInsider - December 09, 08:19AM from (www.streetinsider.com) more ...
Hi-Tech Pharmacal Reports Sales and Earnings for the Second Fiscal Quarter Ended October 31, 2009
HITK Linked by BusinessWire - December 09, 08:00AM from (www.businesswire.com) Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the quarter ended October 31, 2009. For the three months more ...
Hi-Tech Pharmacal to Release Second Quarter Earnings and Hold Conference Call on December 9, 2009
HITK Linked by BusinessWire - December 04, 08:00AM from (www.businesswire.com) Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its second quarter of Fiscal more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|